Optigenex Inc. (OPGX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025

Optigenex Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2010FY 2009FY 2007FY 2006FY 2005
Period Ending
Dec '10 Dec '09 Dec '07 Dec '06 Dec '05
0.990.690.470.30.28
Revenue Growth (YoY)
44.17%47.55%54.85%8.31%-18.06%
Cost of Revenue
0.360.190.571.520.51
Gross Profit
0.630.5-0.1-1.21-0.23
Selling, General & Admin
0.960.821.032.364.12
Research & Development
--0.010.10.33
Operating Expenses
0.960.821.292.754.73
Operating Income
-0.33-0.32-1.39-3.97-4.96
Interest Expense
-0.36-0.38-2.8-9.97-0.78
Earnings From Equity Investments
----0.02-0.03
Other Non Operating Income (Expenses)
--1.297.530.04
EBT Excluding Unusual Items
-0.69-0.7-2.9-6.42-5.72
Asset Writedown
----0.94-1.27
Pretax Income
-0.69-0.7-2.9-7.36-7
Net Income
-0.69-0.7-2.9-7.36-7
Net Income to Common
-0.69-0.7-2.9-7.36-7
Shares Outstanding (Basic)
00---
Shares Outstanding (Diluted)
00---
Shares Change (YoY)
161.42%----
EPS (Basic)
-5.78-15.48---
EPS (Diluted)
-5.78-15.48---
Free Cash Flow
---0.4-2.5-5.06
Gross Margin
63.27%72.65%-22.10%--83.91%
Operating Margin
-33.29%-46.46%-298.48%-1318.37%-1786.66%
Profit Margin
-69.12%-102.15%-621.88%-2444.96%-2518.13%
Free Cash Flow Margin
---85.07%-831.83%-1822.56%
EBITDA
---1.19-3.71-4.69
EBITDA Margin
---254.68%--
D&A For EBITDA
--0.20.250.28
EBIT
-0.33-0.32-1.39-3.97-4.96
EBIT Margin
-33.29%-46.46%-298.48%--
Advertising Expenses
----0.41
Source: S&P Global Market Intelligence. Standard template. Financial Sources.